News
ABTI
0.0051
NaN%
--
Weekly Report: what happened at ABTI last week (0908-0912)?
Weekly Report · 09/15/2025 10:58
Weekly Report: what happened at ABTI last week (0901-0905)?
Weekly Report · 09/08/2025 10:59
Weekly Report: what happened at ABTI last week (0825-0829)?
Weekly Report · 09/01/2025 10:56
Weekly Report: what happened at ABTI last week (0818-0822)?
Weekly Report · 08/25/2025 11:05
Weekly Report: what happened at ABTI last week (0811-0815)?
Weekly Report · 08/18/2025 10:58
Weekly Report: what happened at ABTI last week (0804-0808)?
Weekly Report · 08/11/2025 11:04
Weekly Report: what happened at ABTI last week (0728-0801)?
Weekly Report · 08/04/2025 11:06
Weekly Report: what happened at ABTI last week (0721-0725)?
Weekly Report · 07/28/2025 11:08
Weekly Report: what happened at ABTI last week (0714-0718)?
Weekly Report · 07/21/2025 10:58
Weekly Report: what happened at ABTI last week (0707-0711)?
Weekly Report · 07/14/2025 11:07
Weekly Report: what happened at ABTI last week (0630-0704)?
Weekly Report · 07/07/2025 10:59
More
Webull provides a variety of real-time ABTI stock news. You can receive the latest news about Alterola Biotech through multiple platforms. This information may help you make smarter investment decisions.
About ABTI
Alterola Biotech, Inc. is a pharmaceutical company. The Company is engaged in the development of cannabinoid, cannabinoid-like, and non-cannabinoid pharmaceutical active pharmaceutical ingredients (APIs); pharmaceutical medicines made from cannabinoid, cannabinoid-like, and non-cannabinoid APIs; and European food approval of cannabinoid-based, cannabinoid-like, and non-cannabinoid ingredients and products. The Company has three areas of focus: development of regulated pharmaceuticals (human and animal health) and regulated food products; production of APIs and food-grade ingredients; and formulation, and drug delivery, providing bioavailability, solubility, and stability. It also focuses on developing new medicines from various sources, including botanical, traditional chemical synthesis, and biosynthetic methodologies. Its wholly owned subsidiaries include ABTI Pharma Ltd, Phytotherapeutix Ltd, and Ferven Ltd.